Newton Charles W. Insider Trades

Insider Trading History

Track insider trading activity for Newton Charles W.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Novavax
Novavax NVAX
Director
Holding Value $194k 19,040 shares
Last Trade
Apr 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.3k 9,520 shares
$8.22
$10.19
Novavax
Novavax NVAX
Director
Holding Value $97k 9,520 shares
Last Trade
Apr 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.3k 9,520 shares
$8.22
$10.19
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $159k 14,788 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 28,003 shares
$11.35
$10.77
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $200k 15,306 shares
Last Trade
Aug 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.3k 1,453 shares
$10.54
$13.05
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $219k 16,759 shares
Last Trade
Aug 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.2k 8,000 shares
$10.65
$13.05
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $114k 8,759 shares
Last Trade
Aug 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.41k 136 shares
$10.34
$13.05
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $116k 8,895 shares
Last Trade
Aug 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.38k 131 shares
$10.53
$13.05
Coherus Biosciences
Coherus Biosciences CHRS
Director
Holding Value $176k 112,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.5k 112,000 shares
$0.79
$1.58
2seventy bio
2seventy bio TSVT
Director
Holding Value $0 0 shares
Last Trade
May 13, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$27.7k 5,533 shares
$5.00
$5.00
2seventy bio
2seventy bio TSVT
Director
Holding Value $27.7k 5,533 shares
Last Trade
May 13, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$227k 45,450 shares
$5.00
$5.00
Novavax
Novavax NVAX
Director
Holding Value $437k 42,840 shares
Last Trade
Apr 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$287k 42,840 shares
$6.70
$10.19
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $2.61M 200,000 shares
Last Trade
Mar 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.07M 200,000 shares
$10.34
$13.05
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $5.87M 450,000 shares
Last Trade
Feb 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.6M 506,250 shares
$11.07
$13.05
2seventy bio
2seventy bio TSVT
Director
Holding Value $113k 22,625 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.4k 12,050 shares
$3.93
$5.00
Coherus Biosciences
Coherus Biosciences CHRS
Director
Holding Value $176k 112,000 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 112,000 shares
$1.76
$1.58
2seventy bio
2seventy bio TSVT
Director
Holding Value $167k 33,400 shares
Last Trade
Mar 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$152k 33,400 shares
$4.54
$5.00
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $5.22M 400,000 shares
Last Trade
Feb 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.4M 400,000 shares
$36.00
$13.05
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $47.1M 3,612,000 shares
Last Trade
Nov 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180M 4,818,000 shares
$37.40
$13.05
Lyell Immunopharma
Lyell Immunopharma LYEL
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 16, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$38M 1,016,000 shares
$37.40
$13.05
Coherus Biosciences
Coherus Biosciences CHRS
Director
Holding Value $60.2k 38,250 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 38,250 shares
$5.38
$1.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up